SA22 Does the Use of Investigator-Choice Comparator Arms in Oncology Clinical Trials Influence Payer Assessments Outcomes?

Abstract

Authors

J Mckendrick B Fora E Dubinskaya Doran C Escober

Full Text Cite This Article
Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×